Clinical Trial Update: Supporting Health Including Endocrine Treatment for Long Duration [NA]

View source ↗

Summary

An update on a Dana-Farber Cancer Institute breast cancer trial that is not yet recruiting and involves long-duration endocrine treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer, Breast Cancer - Female | NA | Status: NOT_YET_RECRUITING